erythromycin
erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.
Cross Reference
Introduction
To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with erythromycin?
erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (35)
- J. Antimicrob. Chemother. (18)
- Clin. Infect. Dis. (2)
- Others (29)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with erythromycin
PubChem Associated disorders and diseases
What pathways are associated with erythromycin
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with erythromycin?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with erythromycin?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with erythromycin?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with erythromycin?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (19)
- J. Antimicrob. Chemother. (10)
- Drug Metab. Dispos. (5)
- Others (29)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with erythromycin?
Mouse Model
Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).
Knock-out
Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with erythromycin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Van Herwaarden MA et al. | The effect of motilin agonist ABT-229 on gastro-oesophageal reflux, oesophageal motility and lower oesophageal sphincter characteristics in GERD patients. | 2000 | Aliment. Pharmacol. Ther. | pmid:10759625 |
| Russo A et al. | Effect of the motilin agonist KC 11458 on gastric emptying in diabetic gastroparesis. | 2004 | Aliment. Pharmacol. Ther. | pmid:15274670 |
| Haans JJ and Masclee AA | Review article: The diagnosis and management of gastroparesis. | 2007 | Aliment. Pharmacol. Ther. | pmid:18081647 |
| Bai Y et al. | Meta-analysis: erythromycin before endoscopy for acute upper gastrointestinal bleeding. | 2011 | Aliment. Pharmacol. Ther. | pmid:21615438 |
| Netzer P et al. | Effects of ABT-229, a motilin agonist, on acid reflux, oesophageal motility and gastric emptying in patients with gastro-oesophageal reflux disease. | 2002 | Aliment. Pharmacol. Ther. | pmid:12182748 |
| Athanasakis E et al. | Octreotide enhances the accelerating effect of erythromycin on gastric emptying in healthy subjects. | 2002 | Aliment. Pharmacol. Ther. | pmid:12182757 |
| Chen CL et al. | Efficacy of a motilin receptor agonist (ABT-229) for the treatment of gastro-oesophageal reflux disease. | 2002 | Aliment. Pharmacol. Ther. | pmid:11929393 |
| Bell GD et al. | Short report: omeprazole plus antibiotic combinations for the eradication of metronidazole-resistant Helicobacter pylori. | 1992 | Aliment. Pharmacol. Ther. | pmid:1486161 |
| Brand RM et al. | Transdermal delivery of erythromycin lactobionate--implications for the therapy of gastroparesis. | 1997 | Aliment. Pharmacol. Ther. | pmid:9218087 |
| Annese V et al. | Cisapride and erythromycin prokinetic effects in gastroparesis due to type 1 (insulin-dependent) diabetes mellitus. | 1997 | Aliment. Pharmacol. Ther. | pmid:9218089 |
| Chiba T et al. | Motilides accelerate regional gastrointestinal transit in the dog. | 2000 | Aliment. Pharmacol. Ther. | pmid:10886053 |
| Minocha A et al. | Erythromycin shortens orocaecal transit time in diabetic male subjects: a double-blind placebo-controlled study. | 1995 | Aliment. Pharmacol. Ther. | pmid:8580273 |
| Landry C et al. | Could oral erythromycin optimize high energy continuous enteral nutrition? | 1996 | Aliment. Pharmacol. Ther. | pmid:8971296 |
| Ehrenpreis ED et al. | Which form of erythromycin should be used to treat gastroparesis? A pharmacokinetic analysis. | 1998 | Aliment. Pharmacol. Ther. | pmid:9690728 |
| Medhus AW et al. | Low-dose intravenous erythromycin: effects on postprandial and fasting motility of the small bowel. | 2000 | Aliment. Pharmacol. Ther. | pmid:10651665 |
| Curry JI et al. | Review article: erythromycin as a prokinetic agent in infants and children. | 2001 | Aliment. Pharmacol. Ther. | pmid:11328252 |
| Boecxstaens V et al. | Modulation of the postprandial acid and bile pockets at the gastro-oesophageal junction by drugs that affect gastric motility. | 2011 | Aliment. Pharmacol. Ther. | pmid:21517922 |
| Laine L et al. | Prospective evaluation of the macrolide antibiotic dirithromycin for the treatment of Helicobacter pylori. | 1996 | Aliment. Pharmacol. Ther. | pmid:8791949 |
| Wehrmann T et al. | Effect of erythromycin on human biliary motility. | 1996 | Aliment. Pharmacol. Ther. | pmid:8791972 |
| Mosonyi L et al. | [Infectious and neoplastic complications in rheumatoid arthritis]. | 1974-1975 | Allerg Immunol (Leipz) | pmid:4282826 |
| Sabbah A et al. | [Cell-mediated immunity in antibiotic therapy]. | 1988 | Allerg Immunol (Paris) | pmid:3401307 |
| Sabbah A | [Teldane update. Interview with Dr. Alfred Sabbah, chief of the immuno-allergology laboratory of the C.H.U. d'Angers. Interview by Dr. Pierre Ceddaha]. | 1993 | Allerg Immunol (Paris) | pmid:8466639 |
| Wessel F | [Peri-anesthesia allergies to antibiotics]. | 1998 | Allerg Immunol (Paris) | pmid:9684043 |
| López Serrano C et al. | Urticaria from erythromycin. | 1993 Nov-Dec | Allergol Immunopathol (Madr) | pmid:7512783 |
| San Pedro de Saenz B et al. | FDE to macrolides. | 2002 | Allergy | pmid:11991294 |
| Florido Lopez JF et al. | Fixed eruption due to erythromycin. A case report. | 1991 | Allergy | pmid:1826819 |
| Adamson L and Walum E | Insulin and IGF-1 mediated inhibition of apoptosis in CHO cells grown in suspension in a protein-free medium. | 2007 | Altern Lab Anim | pmid:17650954 |
| Asnes RS and Grebin B | Practical antibiotic therapy in children. | 1973 | Am Fam Physician | pmid:4546004 |
| Snydman DR | Campylobacter Gastroenteritis. | 1982 | Am Fam Physician | pmid:7055019 |
| Miller KE | Diagnosis and treatment of Chlamydia trachomatis infection. | 2006 | Am Fam Physician | pmid:16669564 |
| McSherry JA | Mycoplasma pneumoniae infections. | 1983 | Am Fam Physician | pmid:6837403 |
| Guckian JC | Complications of antimicrobial therapy. | 1973 | Am Fam Physician | pmid:4353071 |
| Pagano JS and Sarubbi FA | Pneumonia. | 1972 | Am Fam Physician | pmid:4642154 |
| Langer R and Binnick S | Treatment of acne vulgaris. | 1979 | Am Fam Physician | pmid:157066 |
| Raz R and Bitnun S | Dilemmas of streptococcal pharyngitis. | 1987 | Am Fam Physician | pmid:3105301 |
| Stott GA | New macrolide antibiotics: clarithromycin and azithromycin. | 1992 | Am Fam Physician | pmid:1325106 |
| Constantine PA | Antibiotic therapy and serum digoxin toxicity. | 1998 | Am Fam Physician | pmid:9531908 |
| Robinson M | Prokinetic therapy for gastroesophageal reflux disease. | 1995 | Am Fam Physician | pmid:7653432 |
| Derrick CW and Dillon HC | Impetigo contagiosa. | 1971 | Am Fam Physician | pmid:5000340 |
| Winkelman L | Recommended revision to endocarditis prophylaxis. | 1991 | Am Fam Physician | pmid:1950954 |
| Kiselica D | Group A beta-hemolytic streptococcal pharyngitis: current clinical concepts. | 1994 | Am Fam Physician | pmid:8154403 |
| Syphilis--recommended treatment schedules, 1976. | 1976 | Am Fam Physician | pmid:961559 | |
| Luft FC | Antimicrobials in kidney and liver failure. | 1976 | Am Fam Physician | pmid:941822 |
| Ackley AM | Legionnaires' disease: an update. | 1981 | Am Fam Physician | pmid:7020390 |
| Johnson WT | Managing odontogenic infections. | 1984 | Am Fam Physician | pmid:6731235 |
| Gonorrhea--recommended treatment schecules, 1974. | 1975 | Am Fam Physician | pmid:123699 | |
| Culp ER | Ilosone update. | 1980 | Am Fam Physician | pmid:7377065 |
| Ocular prophylaxis for gonococcal ophthalmia neonatorum: reaffirmation recommendation statement. | 2012 | Am Fam Physician | pmid:22335221 | |
| Tan HH | Antibacterial therapy for acne: a guide to selection and use of systemic agents. | 2003 | Am J Clin Dermatol | pmid:12688836 |
| Taylor GA and Shalita AR | Benzoyl peroxide-based combination therapies for acne vulgaris: a comparative review. | 2004 | Am J Clin Dermatol | pmid:15301572 |